Tigermed (SHE: 300347, HKG: 3347), a leading China-based Contract Research Organization (CRO), has announced the acquisition of Medical Edge Co., Ltd, a Japan-headquartered CRO. With this strategic move, Medical Edge will become a wholly-owned subsidiary of Tigermed, enhancing the company’s ability to provide high-quality mathematical statistics and electronic data solutions for clinical research in Japan.
Tigermed plans to capitalize on Medical Edge’s established customer base and brand presence in Japan and across Asia to integrate technological strengths and talent resources. This acquisition is set to significantly boost Tigermed’s R&D service capabilities and expand its business footprint in the Asia Pacific region.
Established in 2015, Medical Edge has carved a niche for itself in the development of electronic data capture (EDC) systems, customization services, data analysis, and biostatistics, making it an attractive addition to Tigermed’s global operations.- Flcube.com
